Spero Therapeutics Inc (SPRO)
0.9375
+0.01
(+1.59%)
USD |
NASDAQ |
Dec 24, 16:00
Spero Therapeutics Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| CytomX Therapeutics Inc | 18.17M |
| Castle Biosciences Inc | -14.79M |
| Arbutus Biopharma Corp | -11.99M |
| PTC Therapeutics Inc | -42.68M |
| Equillium Inc | 12.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 12.76M |
| Free Cash Flow | -17.54M |
| Free Cash Flow Per Share (Quarterly) | 0.2358 |
| Free Cash Flow to Equity (Quarterly) | 12.76M |
| Free Cash Flow to Firm (Quarterly) | 12.76M |
| Free Cash Flow Yield | -34.68% |